BRAINBox Solutions

BRAINBox Solutions

Private
Richmond, VirginiaHealthcare & Life Scienceshttps://www.brainboxinc.com

Last Round

Series B

Oct 30, 2023

Total Funding Raised

$27M

Momentum Score

50 /100

Company Overview

BRAINBox Solutions is a healthcare technology company that provides a comprehensive platform for the diagnosis and prognosis of mild traumatic brain injury through blood biomarker panels, standard laboratory systems, and neurocognitive testing.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Healthcare Analytics, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

concussion testTBI testmild traumatic brain injurymTBIconcussion diagnosismulti-modality diagnosticsblood test for concussionblood-based biomarkerspoint-of-care testingneurocognitive assessmentconcussion prognosisAI medical diagnosticsclinical decision supporthead injury assessmentbreakthrough device designationpoint-of-care instrumentconcussion managementpediatric concussionsports concussion

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BRAINBox Solutions Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BRAINBox Solutions Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BOct 30, 2023
GrantMar 21, 2022
Series ADec 8, 2020
GrantMay 30, 2018

Key People

Founding team and executive leadership

Donna Edmonds

Chief Executive Officer

Executive Team

Steve Wallace

COO

Executive Team

BRAINBox Solutions Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 30, 2026

    Provided update on TBI diagnostic/prognostic test program progress.

  • Apr 23, 2025

    Integrated diagnostic technologies with Oragenics' therapeutic candidate ONP-002.

BRAINBox Solutions Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BRAINBox Solutions Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BRAINBox Solutions's valuation, stock price, and market status.

Firmographic Details

HeadquartersRichmond, Virginia
Employee Range17
Year Founded2016
Last FundingOct 30, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.